Shares of BioCryst Pharmaceuticals Inc. (Nasdaq: BCRX) continued rising by climbing $1.42 to close at $12.80 over concerns of a potential Ebola outbreak in Dallas.
BioCryst extends gains
October 03, 2014 at 17:24 PM EDT
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.